Best Blood > Product Monographs

Click Product Name to review monograph.

Document Number

Product Name

Effective Date

160-65-01

Red Blood Cells-Leukoreduced

29OCT20

20

160-65-02

Platelets

 20MAY2021

160-65-03

Plasma

 04NOV2019

160-65-04

Cryoprecipitate

 04NOV2019

160-65-05

Albumin

 04NOV2019

160-65-06

Immune Globulin Intravenous Human

15JULY2021

160-65-07

RhIg- Rh Immune Globulin

15MAR2018

160-65-08

Subcutaneous Immune Globulin

28 NOV 2019

160-65-09

C1 Esterase Inhibitor

 28NOV2019

160-65-10

Recombinant Factor VII (rFVIIa) – Niastase RT

 28NOV2019

160-65-12

rFVIII-Kovaltry Antihemophilic Factor Recombinant

24OCT2019

160-65-13

rFVIII-Xyntha Antihemophilic Factor Recombinant

24OCT2019

160-65-14

FXIII-Corifact

24OCT2019

160-65-15

FVIII/vWF Humate P Antihemophilic Factor/vonWillbrand Factor Complex

24OCT2019

160-65-16

FVIII/vWF Wilate Antihemophilic Factor Recombinant

24OCT2019

160-65-17

rFIX BeneFIX  Antihemophilic Factor Recombinant

24OCT2019

160-65-18

FEIBA Anti-Inhibitor Coagulant Complex

24OCT2019

160-65-19

FXI Factor XI Concentrate – Hemoleven

 24OCT2019

160-65-20

Adynovate- Antihemophilic Factor VIII Recombinant  PEGylated

 03DEC20

20

160-65-21

Fibrinogen Concentrate-RiaSTAP

06MAY2021

160-65-22

Prothrombin Complex Concentrates (Octaplex, Beriplex) –

21NOV2019

160-65-25

Hepatitis B Immune Globulin

 28NOV2019

160-65-26

Alprolix-Antihemophilic Factor Recombinant BDD-FC Protein

24OCT2019

160-65-27

Eloctate-Antihemophilic Factor Recombinant BDD-FC Protein

24OCT2019

160-65-28

rFVIII-Nuwiq

24OCT2019

160-65-29

Tetanus B Immune Globulin 28NOV2019

 

160-65-30

Rebinyn Antihemophilic Factor IX, Recombinant PEGylated

 24OCT2019

160-65-31

160-65-32

160-65-33

Obizur Antihemophilic Factor, Recombinant Porcine Sequence

Hemlibra

JIVI, AntihemophilicFactor (recombinent, B-domain deleted, PEGylated)

24OCT2019

28NOV2019

06AUG2020
160-65-35Fibryga (Fibrinogen Concentrate) St. Boniface only19NOV2020

DISCLAIMER: Printed versions of any document may not be the most current version. Although every effort to ensure that all information is accurate and complete, documents and policies are regularly under review and in the process of being amended and blood product information/inserts may change.  The most current version of the policy, and/or product insert/circular of information shall apply.  Users should verify that any policy is the most current policy before acting on it. Contact your facility paging for the Transfusion Medicine Hematopathologist on call if required.